AltMountain

JW Asset Management, LLC

Location not listed · CRD 160805
Hedge fund manager

JW Asset Management, LLC is an SEC-registered investment adviser that reports managing 4 hedge funds on Form ADV. It reports $476.9 million in regulatory assets under management. Its private funds, of all types, hold $476.9 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +18.9% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +66.2% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
$476.9 millionForm ADV Item 5.F
Gross assets of private funds
$476.9 millionAll private fund types, Form ADV
Hedge funds managed
44 private funds in total
Employees
6Form ADV Item 5.A
Registration
SEC-registered adviserCRD 160805
Latest Form ADV
03/20/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.

Estimated from 13F · 2026 YTD+18.9%Through Q2 2026 · S&P 500 +9.5%
Estimated from 13F · 2 years+66.2%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$319.9 million21 positions, 2026-06-30
$87$127$166Q3 2024Q1 2025Q3 2025Q1 202613F est. $166S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026+47.5%+14.8%
Q1 2026-19.4%-4.6%
Q4 2025+46.3%+2.4%
Q3 2025+2.2%+7.8%
Q2 2025+7.0%+10.4%
Q1 2025-11.5%-4.5%
Q4 2024+3.9%+2.1%
Q3 2024-4.9%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.

13F holdings as of Sep 30, 2026

All 29 share positions ($239,689,210) reported by JW Asset Management, LLC on Form 13F for the quarter ended Sep 30, 2026, filed Nov 6, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.

Share of the reported 13F portfolio, ten largest positions

  • Establishment Labs Hldgs Inc65.62%
  • Sandisk Corp5.23%
  • Vita Coco Co Inc5.22%
  • Dell Technologies Inc3.93%
  • Micron Technology Inc3.11%
  • Ligand Pharmaceuticals Inc1.95%
  • Sharkninja Inc1.95%
  • Ralph Lauren Corp1.78%
  • Idaho Strategic Resources1.65%
  • Nvidia Corporation1.45%
StockValue% of 13F portfolioSharesShares vs prior quarter
Establishment Labs Hldgs Inc$157,284,96965.62%2,451,067-8.98%
Sandisk Corp$12,544,6075.23%7,210-7.68%
Vita Coco Co Inc$12,517,1455.22%218,621Unchanged
Dell Technologies Inc$9,414,1253.93%17,500+400.00%
Micron Technology Inc$7,455,7703.11%7,000Unchanged
Ligand Pharmaceuticals Inc$4,685,5501.95%15,000+275.00%
Sharkninja Inc$4,683,1201.95%26,000New
Ralph Lauren Corp$4,260,8401.78%12,000+20.00%
Idaho Strategic Resources$3,953,5161.65%141,197Unchanged
Nvidia Corporation$3,482,7951.45%15,250Unchanged
Five Below Inc$2,726,6201.14%12,418+24.18%
Cava Group Inc$2,705,0001.13%50,000Unchanged
Travere Therapeutics Inc$2,649,6001.11%45,000+50.00%
Jazz Pharmaceuticals PLC$2,546,7201.06%11,000New
Kiniksa Pharmaceuticals Intl$1,641,4200.68%22,000New
Trulieve Cannabis Corp$914,1720.38%83,869New
Marvell Technology Inc$845,4720.35%3,200Unchanged
Urogen Pharma LTD$812,6000.34%20,000New
Tarsus Pharmaceuticals Inc$707,4900.30%9,000New
Advisorshares TR$700,6000.29%155,000Unchanged
Eton Pharmaceuticals Inc$689,6570.29%13,394New
Imax Corp$602,8000.25%11,000New
Cinemark Hldgs Inc$391,6500.16%10,500New
Indivior Pharmaceuticals Inc$358,5000.15%10,000New
Uber Technologies Inc$342,5500.14%5,000New
Liquidia Corporation$307,9260.13%10,176Unchanged
High Tide Inc$263,8350.11%96,643Unchanged
Aurora Cannabis Inc$156,0000.07%40,000New
Heron Therapeutics Inc$44,1610.02%140,863-96.24%

Changes since Jun 30, 2026

Comparing the share counts in the two quarter-end filings: 12 new positions, 4 sold out, 5 increased, 3 reduced and 9 unchanged.

Number of positions (a count, not dollars)

  • New positions12
  • Increased5
  • Unchanged9
  • Reduced3
  • Sold out4

New positions

StockValueShares
Sharkninja Inc$4,683,12026,000
Jazz Pharmaceuticals PLC$2,546,72011,000
Kiniksa Pharmaceuticals Intl$1,641,42022,000
Trulieve Cannabis Corp$914,17283,869
Urogen Pharma LTD$812,60020,000
Tarsus Pharmaceuticals Inc$707,4909,000
Eton Pharmaceuticals Inc$689,65713,394
Imax Corp$602,80011,000
Cinemark Hldgs Inc$391,65010,500
Indivior Pharmaceuticals Inc$358,50010,000
Uber Technologies Inc$342,5505,000
Aurora Cannabis Inc$156,00040,000

Sold out

StockValue at Jun 30, 2026Shares held then
Catalyst Pharmaceuticals Inc$12,207,161388,392
Iren Limited$6,614,845144,650
On Hldg AG$2,583,88972,950
Trulieve Cannabis Corp$824,43283,869

Largest increases

StockChange in sharesChangeValue nowShares now
Dell Technologies Inc+14,000+400.00%$9,414,12517,500
Ligand Pharmaceuticals Inc+11,000+275.00%$4,685,55015,000
Travere Therapeutics Inc+15,000+50.00%$2,649,60045,000
Ralph Lauren Corp+2,000+20.00%$4,260,84012,000
Five Below Inc+2,418+24.18%$2,726,62012,418

Largest reductions

StockChange in sharesChangeValue nowShares now
Establishment Labs Hldgs Inc-241,789-8.98%$157,284,9692,451,067
Heron Therapeutics Inc-3,610,210-96.24%$44,161140,863
Sandisk Corp-600-7.68%$12,544,6077,210

Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.

From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures

Large ownership stakes (Schedule 13D and 13G)

CompanyFilingPercent of classSharesFiledSource
Establishment Labs Holdings, Inc.13G9.15%2,692,856Jul 31, 2026SEC.gov ↗

A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Jul 31, 2026, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.

Private funds reported on Form ADV (5)

Fund
Gross assets
Minimum
Owners
Adviser
JW Partners, LP
Delaware, United StatesHedge fund
Gross assets$299M
Minimum$500K
Owners86
AdviserJW Asset Management, LLC
JW Opportunities Master Fund LTD
Cayman IslandsHedge fund
Gross assets$120M
Minimum$500K
Owners236
AdviserJW Asset Management, LLC
JW Select Investments, LP
Delaware, United StatesHedge fund
Gross assets$21.3M
Minimum$500K
Owners82
AdviserJW Asset Management, LLC
JW Growth Fund, LLC
Delaware, United StatesHedge fund
Gross assets$8.0M
Minimum$500K
Owners47
AdviserJW Asset Management, LLC
Insight Wellness Fund, LLC
Delaware, United StatesHedge fund
Gross assets$2.0M
Minimum$100K
Owners23
AdviserJW Asset Management, LLC

As reported in the adviser's Form ADV filed Mar 22, 2024. Funds also listed from Form D are shown above.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​​⁠